MIST Milestone Pharmaceuticals Inc.
$0.37
Milestone Pharmaceuticals Inc. (MIST) Earnings News
Earnings press releases, previews and reviews for Milestone Pharmaceuticals Inc. (MIST), newest first. Our most recent is review: Milestone Pharmaceuticals Beats on a One-Time License Payment, but a 30% Cost Cut Shows the CARDAMYST Launch Is Running Below Plan.
Friday
November 13, 2026
10:42 AM ET
Milestone Pharmaceuticals Beats on a One-Time License Payment, but a 30% Cost Cut Shows the CARDAMYST Launch Is Running Below Plan
Earnings Whispers · Review
Friday
November 13, 2026
7:08 AM ET
Milestone Pharmaceuticals Reports Third Quarter 2026 Financial Results and Announces Cost-Efficiency Measures Designed to Extend Cash Runway Through AFib-RVR Phase 3 Data
Thursday
November 5, 2026
8:28 PM ET
Milestone's Cardamist Launch Faces Its Pricing Test as Coverage Tops 50% and Shares Slide
Earnings Whispers · Preview
Tuesday
November 3, 2026
8:00 AM ET
Milestone Pharmaceuticals to Announce Third Quarter 2026 Financial Results on November 13, 2026
Wednesday
August 12, 2026
7:08 AM ET
Milestone Pharmaceuticals Announces Second Quarter 2026 Financial Results and Provides Corporate Update
Tuesday
August 4, 2026
4:01 PM ET
Milestone Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 12, 2026